Literature DB >> 1899938

Mortality, cardiovascular risk factors, and diet in China, Finland, and the United States.

E Vartiainen1, D J Du, J S Marks, H Korhonen, G Y Geng, Z Y Guo, J P Koplan, P Pietinen, G L We, D Williamson.   

Abstract

Mortality, cardiovascular risk factors, and diet were compared in Tianjin province, People's Republic of China; in North Karelia Province, Finland; and in the United States as a whole. People in Tianjin received 7 percent of their energy intake from saturated fats, whereas people in the United States received 13 percent and those in North Karelia received 20. The mean blood cholesterol levels for men were 158 milligrams per deciliter (mg per dl) for Tianjin, 216 mg per dl for the United States, and 241 mg per dl for North Karelia. The smoking prevalence among men was highest in Tianjin (66 percent), followed by the United States (42 percent) and Finland (36 percent). The differences among mortality rates for the three locales were less pronounced among women than among men. Age-standardized total mortality for women was highest for Tianjin and lowest in North Karelia. The reverse was true for men. Age-standardized total mortality for men was lowest in Tianjin and highest in North Karelia. Age-standardized ischemic heart disease mortality for men was lowest in Tianjin (99 per 100,000) and highest in North Karelia (730 per 100,000). For women, the corresponding figures were 83 per 100,000 in Tianjin and 164 per 100,000 in North Karelia. Although salt intake was higher in Tianjin than in North Karelia, the blood pressure was on average lower in persons from Tianjin than in those from North Karelia. The stroke mortality rate in Tianjin, however, was much higher than in either Finland or the United States. The strong discrepancy in stroke mortality relative to prevalence of hypertension and salt intake raises the issue of the etiology of stroke in Tianjin. Recently it has been reported that hemorrhagic stroke may be more common among people whose blood cholesterol level is very low and blood pressure level high. This joint condition may be relatively common in Tianjin and calls for longitudinal and case-control studies to clarify the relationships among these factors in Tianjin.

Entities:  

Keywords:  Age Factors; Americas; Asia; Biology; Cardiovascular Effects; China; Comparative Studies; Cross-cultural Comparisons; Demographic Factors; Developed Countries; Developing Countries; Differential Mortality; Eastern Asia; Europe; Finland; Health; Mortality; North America; Northern America; Northern Europe; Nutrition; Physiology; Population; Population Characteristics; Population Dynamics; Research Methodology; Risk Factors; Scandinavia; Sex Factors; Studies; United States

Mesh:

Year:  1991        PMID: 1899938      PMCID: PMC1580197     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  8 in total

1.  Decline in cardiovascular mortality in North Karelia and other parts of Finland.

Authors:  J Tuomilehto; J Geboers; J T Salonen; A Nissinen; K Kuulasmaa; P Puska
Journal:  Br Med J (Clin Res Ed)       Date:  1986-10-25

2.  Diet, physical activity, and colorectal cancer among Chinese in North America and China.

Authors:  A S Whittemore; A H Wu-Williams; M Lee; S Zheng; R P Gallagher; D A Jiao; L Zhou; X H Wang; K Chen; D Jung
Journal:  J Natl Cancer Inst       Date:  1990-06-06       Impact factor: 13.506

Review 3.  Polyunsaturated fatty acids, hyperlipidemia, and thrombosis.

Authors:  S H Goodnight; W S Harris; W E Connor; D R Illingworth
Journal:  Arteriosclerosis       Date:  1982 Mar-Apr

4.  Recent trends in cardiovascular disease mortality in 27 industrialized countries.

Authors:  K Uemura; Z Pisa
Journal:  World Health Stat Q       Date:  1985

5.  Trends of mortality from ischaemic heart disease and other cardiovascular diseases in 27 countries, 1968-1977.

Authors:  Z Pisa; K Uemura
Journal:  World Health Stat Q       Date:  1982

6.  Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened for the multiple risk factor intervention trial.

Authors:  H Iso; D R Jacobs; D Wentworth; J D Neaton; J D Cohen
Journal:  N Engl J Med       Date:  1989-04-06       Impact factor: 91.245

7.  Changes in dietary habits and knowledge concerning salt during a community-based prevention programme for hypertension.

Authors:  P Pietinen; A Tanskanen; A Nissinen; J Tuomilehto; P Puska
Journal:  Ann Clin Res       Date:  1984

8.  Dietary survey of the FINMONICA project in 1982.

Authors:  P Pietinen; U Uusitalo; E Vartiainen; J Tuomilehto
Journal:  Acta Med Scand Suppl       Date:  1988
  8 in total
  6 in total

Review 1.  The complex interplay between cholesterol and prostate malignancy.

Authors:  Keith R Solomon; Michael R Freeman
Journal:  Urol Clin North Am       Date:  2011-06-22       Impact factor: 2.241

2.  Electrocardiographic abnormalities and associated factors in Chinese living in Beijing and in Mauritius. The Mauritius Non-Communicable Disease Study Group.

Authors:  N Li; J Tuomilehto; G Dowse; K G Alberti; P Zimmet; Z Min; P Chitson; H Gareeboo; Y Chonghua; D Fareed
Journal:  BMJ       Date:  1992-06-20

3.  Estimating the risks and prevalence of hypertension in a suburban area of Beijing.

Authors:  L A Aday; A Youssef; S W Liu; W H Chao; C Zhang
Journal:  J Community Health       Date:  1994-10

Review 4.  NADPH Oxidase Activity in Cerebral Arterioles Is a Key Mediator of Cerebral Small Vessel Disease-Implications for Prevention.

Authors:  Mark F McCarty
Journal:  Healthcare (Basel)       Date:  2015-04-15

5.  [Does sealing the oval window in addition to the round window bring an advantage in reserve therapy of acute idiopathic deafness?]

Authors:  V M Hofmann; U Schoenfeld; M Jagielski; A Pudszuhn
Journal:  HNO       Date:  2021-01       Impact factor: 1.284

6.  Prevention and management of CVD in LMICs: why do ethnicity, culture, and context matter?

Authors:  Shuchi Anand; Christina Bradshaw; Dorairaj Prabhakaran
Journal:  BMC Med       Date:  2020-01-24       Impact factor: 8.775

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.